Commercialization


  • pills rising
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

    Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

    By June 2, 2023
  • Laurie Stelzer Mirati
    Image attribution tooltip
    Permission granted by Laurie Stelzer Mirati
    Image attribution tooltip
    Podcast

    Woman of the Week: Mirati Therapeutics’ Laurie Stelzer

    With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.

    By May 31, 2023
  • An illustration of a globe with large multicolored pins pointing to countries.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Taking your biotech global? Here’s how you can navigate cultural norms

    What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

    By Alexandra Pecci • May 2, 2023
  • Peyton Howell Parexel
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Q&A

    5 minutes with — Parexel’s Peyton Howell

    The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."

    By April 7, 2023
  • A scientist with protective eyeglasses and mask holding a red transparent pill with fingers in gloves in the pharmaceutical research laboratory
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A drug just launched for a disease discovered only 10 years ago

    Pharming just landed an FDA approval for a treatment targeting an ultra-rare immunodeficiency disorder discovered only a decade ago — and it’s already in the hands of patients.

    By April 6, 2023
  • A TV remote points up at a blurred-out screen.
    Image attribution tooltip
    simpson33 via Getty Images
    Image attribution tooltip

    Cutting the cord — why streaming is a new frontier for pharma advertising

    As streaming services proliferate, and more TV watchers buy in, there’s a new world of possibilities for DTC pharma marketing.

    By March 27, 2023
  • Chris Fox Novartis Gene Therapies
    Image attribution tooltip
    Permission granted by Chris Fox Novartis Gene Therapies
    Image attribution tooltip
    Podcast

    Woman of the Week: Novartis Gene Therapies’ Chris Fox

    Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. When Novartis acquired AveXis and its spinal muscular atroph...

    By March 15, 2023
  • Senior older women
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Targeting the new ‘Golden Girls’

    With unprecedented buying power, women over 50 wield a lot of influence — but are still underserved by pharma. Urovant hopes to change that with its potential blockbuster drug.

    By March 8, 2023
  • drug injection cost
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Multimillion-dollar therapies are changing how payers foot the bill

    With more gene therapies headed to market, novel payment methods are emerging from regulators and academia. 

    By Feb. 28, 2023
  • patient care
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Why patient care is a public affair

    The VP of public affairs at Kyowa Kirin discusses her role in advocating for advocacy.

    By Feb. 23, 2023
  • Ester Banque Bristol Myers Squibb
    Image attribution tooltip
    Permission granted by Ester Banque Bristol Myers Squibb
    Image attribution tooltip
    Podcast

    Woman of the Week: Bristol Myers Squibb’s Ester Banque

    The 30-year veteran is heading up the “transformation” of one of the pharma giant’s most important therapeutic portfolios: hematology.

    By Feb. 15, 2023
  • Multicolored wave lines in the shape of an eye
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    For Complement’s CEO, storytelling could be just as critical as data

    Dr. Rafiq Hasan has his sights on bringing lessons learned at Bayer to ophthalmology-focused Complement Therapeutics.

    By Alexandra Pecci • Feb. 14, 2023
  • Professional headshot of Brian Fox
    Image attribution tooltip
    Permission granted by Klick Group
    Image attribution tooltip
    Q&A // First 90 Days

    Brian Fox is bringing ‘fresh eyes’ to ad agency Klick

    Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

    By Feb. 13, 2023
  • Doctor sits at her office and using mobile smart phone
    Image attribution tooltip

    Lordn/Shutterstock.com

    Image attribution tooltip
    Sponsored by LiveWorld

    Survey results: Social influences HCP perceptions and prescriptions

    Build social strategies into marketing plans to reach HCPs with sharply focused messaging.

    Feb. 13, 2023
  • The Federal Trade Commission headquarters is pictured in Washington, D.C. The agency's proposed noncompete ban may face legal challenges on several grounds.
    Image attribution tooltip
    RiverNorthPhotography via Getty Images
    Image attribution tooltip

    Antitrust watchdogs have pharma in their sights, and the landscape is getting thornier

    The FTC and DOJ are heightening antitrust enforcement, and pharma deals are a prime target.

    By Feb. 2, 2023
  • Yesmean Wahdan Bayer
    Image attribution tooltip
    Permission granted by Yesmean Wahdan Bayer
    Image attribution tooltip
    Podcast

    Woman of the Week: Bayer’s Dr. Yesmean Wahdan

    The VP of medical affairs and women’s health is focused on an audacious goal to meet the needs of 100 million women globally.

    By Feb. 1, 2023
  • booster
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Vaxxinity eyes global COVID-19 vaccine market with ‘next-gen’ booster

    The biotech aims to complete rolling submissions with regulators in the U.K. and Australia in the first half of 2023.

    By Alexandra Pecci • Jan. 31, 2023
  • Teens in circle holding smart mobile phones of different colors.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Patients are using social media — clinical trial experts can learn from that

    Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights. 

    By Jan. 30, 2023
  • scale
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Weight loss drugs: the promise and pitfalls

    GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.

    By Kelly Bilodeau • Jan. 30, 2023
  • Woman relaxing on sofa, enjoying web surfing information in internet
    Image attribution tooltip

    Fizkes/Shutterstock.com

    Image attribution tooltip
    Sponsored by LiveWorld

    Boost returns from social strategies with new channels and tactics

    Emerging channels offer new ways to reach key targets and improve campaign ROI.

    Jan. 30, 2023
  • A brown building with white vertical sign with the Twitter logo
    Image attribution tooltip
    Justin Sullivan/Staff via Getty Images
    Image attribution tooltip

    With Twitter in flux, pharma is turning to alternative social spaces

    Elon Musk’s takeover of Twitter has upended the ways pharma companies communicate with doctors online. Now new social strategies are emerging.

    By Jan. 26, 2023
  • Johanna Mercier headshot
    Image attribution tooltip
    Permission granted by Gilead Sciences
    Image attribution tooltip
    Q&A

    Gilead’s commercial chief on why 2023 will be a ‘coming out’ year

    With a rapidly expanding oncology pipeline and a new approval in HIV, Johanna Mercier discusses Gilead’s quest to transform.

    By Jan. 26, 2023
  • Lauren Lazar Calcium
    Image attribution tooltip
    Permission granted by Lauren Lazar Calcium
    Image attribution tooltip
    Podcast

    Woman of the Week: Dr. Lauren Lazar

    As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic connections between science and marketing for healthcare brands.

    By Jan. 25, 2023
  • 3D Illustration Concept of Human Respiratory System Lungs Anatomy
    Image attribution tooltip
    magicmine, iStock / Getty Images Plus via Getty Images
    Image attribution tooltip

    AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships

    A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra.

    By Jan. 24, 2023
  • A prescription bottle with white pills and a wooden gavel sit atop a $100 bill showing Benjamin Franklin's face.
    Image attribution tooltip
    Bill Oxford via Getty Images
    Image attribution tooltip

    Drug price negotiations: 5 key dates to watch

    As the CMS readies its new program for lowering drug costs, these are the moments that will matter most to pharma companies.

    By Kelly Bilodeau • Jan. 23, 2023